Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Efficacy of Pimozide Augmentation for Clozapine Partial Response

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Pimozide
Drug: placebo

First Posted Date: 2006-09-11

Last Posted Date: 2016-03-04

Lead Sponsor: Yale University

Target Recruit Count: 28

Registration Number: NCT00374244

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Continuous Positive Airway Pressure for the Treatment of Stroke

Phase 2

Completed

Conditions: Acute Ischemic Stroke
Sleep Apnea

First Posted Date: 2006-08-25

Last Posted Date: 2009-03-03

Lead Sponsor: Yale University

Target Recruit Count: 55

Registration Number: NCT00368628

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction

Phase 2

Completed

Conditions: Myocardial Infarction

Interventions: Drug: Recombinant human erythropoietin alfa (drug)
Drug: Placebo

First Posted Date: 2006-08-24

Last Posted Date: 2018-01-12

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT00367991

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

Phase 2

Completed

Conditions: Healthy Subjects

First Posted Date: 2006-08-24

Last Posted Date: 2006-08-24

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT00368238

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Directly Observed Antiretroviral Therapy Among Active Drug Users

Not Applicable

Completed

Conditions: HIV/AIDS
Substance Abuse

First Posted Date: 2006-08-22

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 125

Registration Number: NCT00367172

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

CBT With Disulfiram and Contingency Management

Phase 1

Completed

Conditions: Cocaine Abuse

Interventions: Drug: Placebo
Behavioral: Placebo plus Contingency Management
Drug: Disulfiram plus Contingency Management
Drug: disulfiram

First Posted Date: 2006-07-11

Last Posted Date: 2014-12-03

Lead Sponsor: Yale University

Target Recruit Count: 181

Registration Number: NCT00350870

Locations: 🇺🇸
APT Foundation, New Haven, Connecticut, United States

Computer-Based Training in Cognitive Behavior Therapy

Phase 1

Completed

Conditions: Cocaine Abuse

Interventions: Other: Treatment as usual (TAU)
Behavioral: CBT for CBT

First Posted Date: 2006-07-11

Last Posted Date: 2013-01-29

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00350610

Locations: 🇺🇸
APT Foundation Orchard Hill Clinic, New Haven, Connecticut, United States

Brief Interventions for Drop-out Re-engagement

Phase 1

Completed

Conditions: Substance Abuse

Interventions: Behavioral: brief (behavioral therapy)
Behavioral: standard care follow up
Behavioral: Drop out re-engagement motivational intervention

First Posted Date: 2006-07-11

Last Posted Date: 2014-09-17

Lead Sponsor: Yale University

Target Recruit Count: 299

Registration Number: NCT00350571

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸
APT Foundation, New Haven, Connecticut, United States

Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management

Phase 2

Completed

Conditions: Marijuana Dependence

Interventions: Behavioral: CBT+CM/adherence
Behavioral: Standard CBT
Behavioral: CM/abstinence
Behavioral: CM/abstinence+CBT

First Posted Date: 2006-07-11

Last Posted Date: 2011-09-27

Lead Sponsor: Yale University

Target Recruit Count: 205

Registration Number: NCT00350649

Locations: 🇺🇸
ASAP/1 Long Wharf, New Haven, Connecticut, United States

Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer

Not Applicable

Completed

Conditions: Menopause

First Posted Date: 2006-07-06

Last Posted Date: 2023-08-30

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00349011

Locations: 🇺🇸
Yale Cancer Genetic Counseling, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy